FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
3,008 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Intestipargentiana lutea, arsenicum album, cinchona officinalis, colocynthis, nux vomica, phosphorus, small intestine (suis) | Gentiana lutea root 3 [hp_X]/mL + 6 more ingredients | LiquidOral | Energique, Inc. | Unapproved homeopathic | 44911-0323 | 44911-0323-01 | — |
| Intestipargentiana lutea, arsenicum album, berberinum, cinchona officinalis, colocynthis, hydrastis canadensis, indolum, lycopodium clavatum, natrum sulphuricum, nux vomica, phosphorus, small intestine (suis) | Gentiana lutea root 3 [hp_X]/mL + 11 more ingredients | LiquidOral | Energique, Inc. | Unapproved homeopathic |
| 44911-0908 |
| 44911-0908-01 |
| — |
| INTIMALE Benzocaine Delay Gelbenzocaine | Benzocaine 50 mg/mL | GelTopical | SKINS SEXUAL HEALTH LIMITED | OTC monograph drug | 81923-369 | 81923-0369-00 | — |
|---|
| Intimale Lidocaine Delaylidocaine hydrochloride | Lidocaine hydrochloride 10 mg/mL | SolutionTopical | SKINS SEXUAL HEALTH LIMITED | OTC monograph drug | 81923-368 | 81923-0368-00 | — |
|---|
| INTIMALE Maximum Strength Delaylidocaine hydrochloride | Lidocaine hydrochloride 10 mg/mL | SolutionTopical | SKINS SEXUAL HEALTH LIMITED | OTC monograph drug | 81923-197 | 81923-0197-00 | — |
|---|
| Intimatenatrum carbonicum, saccharum officinale, lithium carbonicum, placenta totalis suis, lac caninum, anacardium orientale, aurum muriaticum natronatum, camphora, germanium metallicum, helleborus niger, magnesia oxydata, rhus glabra, stramonium, thuja occidentalis, dna (human), oxytocin, hydrogen, neon, lac materna humanum | Sodium carbonate 6 [hp_X]/mL + 18 more ingredients | LiquidOral | Deseret Biologicals, Inc. | Unapproved homeopathic | 43742-1620 | 43742-1620-01 | — |
|---|
| Intimateanacardium orientale, aurum muriaticum natronatum, camphora, dna (human), germanium metallicum, helleborus niger, hydrogen, lac caninum, lac materna humanum, lithium carbonicum, magnesia oxydata, natrum carbonicum, neon, oxytocin, placenta totalis suis, rhus glabra, saccharum officinale, stramonium, thuja occidentalis | Semecarpus anacardium juice 12 [hp_X]/mL + 18 more ingredients | LiquidOral | Deseret Biologicals, Inc. | Unapproved homeopathic | 43742-2185 | 43742-2185-01 | — |
|---|
| Intimate CareGelhyaluronic acid | Hyaluronic acid .02 g/3g | GelTopical | Guangzhou Yilong Cosmetics.,Ltd | OTC monograph drug | 74458-189 | 74458-0189-05 | — |
|---|
| Intral Sensitive Skin Environmental Lightweight Shield Broad Spectrum SPF50titanium dioxide and zinc oxide | Titanium dioxide 63 mg/mL; Zinc oxide 40 mg/mL | LotionTopical | DARPHIN DIST. | OTC monograph drug | 16555-008 | 16555-0008-01 | — |
|---|
| Intralipidi.v. fat emulsion | Soybean oil 10 g/100mL | EmulsionIntravenous | Baxter Healthcare CORP | NDA | 0338-0518 | 00338-0518-1200338-0518-1300338-0518-58 | — |
|---|
| Intralipidi.v. fat emulsion | Soybean oil 20 g/100mL | EmulsionIntravenous | Baxter Healthcare Corporation | NDA | 0338-0519 | 00338-0519-0900338-0519-1300338-0519-58 | — |
|---|
| Intralipidi. v. fat emulsion | Soybean oil 30 g/100mL | EmulsionIntravenous | Baxter Healthcare Corporation | NDA | 0338-0520 | 00338-0520-13 | — |
|---|
| Intralipidi.v. fat emulsion | Soybean oil 20 g/100mL | EmulsionIntravenous | Fresenius Kabi USA, LLC | NDA | 65219-531 | 65219-0531-10 | — |
|---|
| Intralipidi.v. fat emulsion | Soybean oil 20 g/100mL | EmulsionIntravenous | Fresenius Kabi USA, LLC | NDA | 65219-533 | 65219-0533-25 | — |
|---|
| Intralipidi.v. fat emulsion | Soybean oil 20 g/100mL | EmulsionIntravenous | Fresenius Kabi USA, LLC | NDA | 65219-535 | 65219-0535-50 | — |
|---|
| Intralipidi.v. fat emulsion | Soybean oil 30 g/100mL | EmulsionIntravenous | Fresenius Kabi USA, LLC | NDA | 65219-537 | 65219-0537-50 | — |
|---|
| Intralipidi.v. fat emulsion | Soybean oil 20 g/100mL | EmulsionIntravenous | Fresenius Kabi USA, LLC | NDA | 65219-539 | 65219-0539-10 | — |
|---|
| Intralipidi.v. fat emulsion | Soybean oil 20 g/100mL | EmulsionIntravenous | ProPharma Distribution | NDA | 84549-533 | 84549-0533-25 | — |
|---|
| Intralipidi.v. fat emulsion | Soybean oil 20 g/100mL | EmulsionIntravenous | ProPharma Distribution | NDA | 84549-535 | 84549-0535-50 | — |
|---|
| Intrarosaprasterone | Prasterone 6.5 mg/1 | InsertVaginal | Millicent US, Inc. | NDA | 72495-401 | 72495-0401-28 | — |
|---|
| Intrarosaprasterone | Prasterone 6.5 mg/1 | InsertVaginal | Millicent US, Inc. | NDA | 72495-501 | 72495-0501-14 | — |
|---|
| Introstem PrismaStem Face Shield Creamoctinoxate, homosalate, octisalate, oxybenzone and avobenzone | Octinoxate 7.4 g/100g + 4 more ingredients | CreamTopical | Innovation Brands Inc. | OTC monograph drug | 72104-042 | 72104-0042-01 | — |
|---|
| Introstem Vitiscell Facial Shieldoctinoxate, homosalate, octisalate, oxybenzone and avobenzone | Octinoxate 7.4 g/100g + 4 more ingredients | CreamTopical | Innovation Brands Inc. | OTC monograph drug | 72104-082 | 72104-0082-72 | — |
|---|
| Introvalelevonorgestrel and ethinyl estradiol | — | Kit | Xiromed, LLC. | ANDA | 70700-117 | 70700-0117-87 | — |
|---|
| Introvalelevonorgestrel and ethinyl estradiol tablets | — | Kit | Xiromed LLC | ANDA | 70700-208 | 70700-0208-88 | — |
|---|
| Introvert Formulapassiflora incarnata, pulsatilla (pratensis), ignatia amara, natrum muriaticum, duodenum (suis), petroleum, sulphur | Passiflora incarnata flowering top 3 [hp_X]/mL + 6 more ingredients | SprayOral | Nutritional Specialties, Inc. | Unapproved homeopathic | 83027-0086 | 83027-0086-01 | — |
|---|
| Intunivguanfacine | Guanfacine hydrochloride 1 mg/1 | Tablet, Extended releaseOral | Takeda Pharmaceuticals America, Inc. | NDA | 54092-513 | 54092-0513-02 | — |
|---|
| Intunivguanfacine | Guanfacine hydrochloride 2 mg/1 | Tablet, Extended releaseOral | Takeda Pharmaceuticals America, Inc. | NDA | 54092-515 | 54092-0515-02 | — |
|---|
| Intunivguanfacine | Guanfacine hydrochloride 3 mg/1 | Tablet, Extended releaseOral | Takeda Pharmaceuticals America, Inc. | NDA | 54092-517 | 54092-0517-02 | — |
|---|
| Intunivguanfacine | Guanfacine hydrochloride 4 mg/1 | Tablet, Extended releaseOral | Takeda Pharmaceuticals America, Inc. | NDA | 54092-519 | 54092-0519-02 | — |
|---|
| Invanzertapenem sodium | Ertapenem sodium 1 g/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | Merck Sharp & Dohme LLC | NDA | 0006-3843 | 00006-3843-71 | — |
|---|
| Invegapaliperidone | Paliperidone 3 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | NDA | 50458-550 | 50458-0550-0150458-0550-98 | — |
|---|
| Invegapaliperidone | Paliperidone 6 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | NDA | 50458-551 | 50458-0551-0150458-0551-98 | — |
|---|
| Invegapaliperidone | Paliperidone 9 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | NDA | 50458-552 | 50458-0552-0150458-0552-98 | — |
|---|
| Invegapaliperidone | Paliperidone 1.5 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | NDA | 50458-554 | — | — |
|---|
| Invega Hafyerapaliperidone palmitate | Paliperidone palmitate 1092 mg/3.5mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | NDA | 50458-611 | 50458-0611-01 | — |
|---|
| Invega Hafyerapaliperidone palmitate | Paliperidone palmitate 1560 mg/5mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | NDA | 50458-612 | 50458-0612-01 | — |
|---|
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 39 mg/.25mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | NDA | 50458-560 | 50458-0560-01 | — |
|---|
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 78 mg/.5mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | NDA | 50458-561 | 50458-0561-01 | — |
|---|
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 117 mg/.75mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | NDA | 50458-562 | 50458-0562-01 | — |
|---|
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 156 mg/mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | NDA | 50458-563 | 50458-0563-0150458-0563-03 | — |
|---|
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 234 mg/1.5mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | NDA | 50458-564 | 50458-0564-0150458-0564-03 | — |
|---|
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 273 mg/.88mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | NDA | 50458-606 | 50458-0606-01 | — |
|---|
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 410 mg/1.32mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | NDA | 50458-607 | 50458-0607-01 | — |
|---|
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 546 mg/1.75mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | NDA | 50458-608 | 50458-0608-01 | — |
|---|
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 819 mg/2.63mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | NDA | 50458-609 | 50458-0609-01 | — |
|---|
| Inverness Ear Carebenzalkonium chloride | Benzalkonium chloride 1.2 mg/mL | SolutionTopical | The Richline Group, Inc. | OTC monograph drug | 70094-007 | 70094-0007-01 | — |
|---|
| Inverness EAR CARE ANTISEPTICbenzalkonium chloride | Benzalkonium chloride 1.2 mg/mL | SolutionTopical | The Richline Group | OTC monograph drug | 70094-010 | 70094-0010-0270094-0010-0470094-0010-08 | — |
|---|
| Inverness Ear Piercingbenzalkonium chloride | — | Kit | The Richline Group, Inc. | OTC monograph drug | 70094-002 | 70094-0002-02 | — |
|---|
| Inverness Home Ear Piercing Kitbenzalkonium chloride | — | Kit | The Richline Group, Inc. | OTC monograph drug | 70094-004 | 70094-0004-03 | — |
|---|